Stockscreener 앱 받기
1.55
3.73%
-0.06
시간 외 거래:
1.55
전일 마감가:
$1.61
열려 있는:
$1.63
하루 거래량:
1.64M
Relative Volume:
0.84
시가총액:
$577.00M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.6316
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
-6.06%
1개월 성능:
-11.43%
6개월 성능:
-30.80%
1년 성능:
-31.72%
1일 변동 폭
$1.549
$1.66
1주일 범위
$1.549
$1.68
52주 변동 폭
$1.21
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.55 | 577.00M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools (NASDAQ:LAB) Shares Down 5.8%What's Next? - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by JPMorgan Chase & Co. - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 8.5%Should You Sell? - MarketBeat
Things To Consider Before You Buy Standard BioTools Inc (NASDAQ: LAB) - Stocks Register
Standard BioTools (NASDAQ:LAB) Shares Gap DownHere's Why - MarketBeat
Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors - MSN
Standard BioTools (NASDAQ:LAB) Trading Down 5.8%Here's What Happened - MarketBeat
Standard BioTools stock soars on Q4 revenue beat By Investing.com - Investing.com South Africa
Standard BioTools stock soars on Q4 revenue beat - Investing.com India
Standard BioTools (NASDAQ:LAB) Shares Gap UpWhat's Next? - MarketBeat
Standard BioTools stock soars on upbeat preliminary 4Q revenue By Investing.com - Investing.com Canada
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Standard BioTools Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
Standard BioTools Reports 2024 Revenue Achievements and Plans - TipRanks
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - The Manila Times
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$52m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St
Standard BioTools Hits Top-End Revenue Target of $174M, Slashes Operating Costs in 2024 - StockTitan
Standard BioTools announces CCO Jeremy Davis's departure By Investing.com - Investing.com Canada
Standard BioTools announces CCO Jeremy Davis's departure - Investing.com India
Standard BioTools Announces CCO Jeremy Davis’s Departure - TipRanks
Jane Street Group LLC Sells 60,340 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine - The Manila Times
Principal Financial Group Inc. Has $43,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools' SomaScan Platform Breakthrough: Nature Medicine Study Reveals Semaglutide Insights - StockTitan
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap drop, institutional owners may be forced to take severe actions - Yahoo Finance
Geode Capital Management LLC Buys 154,848 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.3%Should You Sell? - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Acquired by State Street Corp - MarketBeat
State Street Corp Purchases 1,157,984 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Barclays PLC Purchases 377,195 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Standard BioTools CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan
Standard BioTools (NASDAQ:LAB) Trading Down 6.8%Here's What Happened - MarketBeat
BNP Paribas Financial Markets Lowers Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
After Leaping 35% Standard BioTools Inc. (NASDAQ:LAB) Shares Are Not Flying Under The Radar - Simply Wall St
Standard BioTools (NASDAQ:LAB) Shares Up 9.9%Still a Buy? - MarketBeat
What Are You Thinking About Investing In Standard BioTools Inc (NASDAQ: LAB) Stock? - Stocks Register
Charles Schwab Investment Management Inc. Purchases 1,597,728 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Standard BioTools (STU:FLB) Enterprise Value : €386.4 Mil (As of Nov. 30, 2024) - GuruFocus.com
LAB Stock Price and Chart — NASDAQ:LAB - TradingView
Standard BioTools Inc. (NASDAQ:LAB) Short Interest Down 24.9% in November - MarketBeat
Standard BioTools (NASDAQ:LAB) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 59% - Simply Wall St
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com
Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools names new CFO By Investing.com - Investing.com Australia
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
자본화:
|
볼륨(24시간):